Study on DNA and RNA for Advanced Lung Cancer Treatment
The Role of DNA and RNA in NGS Analyses for Advaced Stage NSCLC Patients
Recruiting
N/A
Interventional Study
Non Small Cell Lung Cancer NSCLC
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Diagnostic
- Participants needed
- 10 (estimated)
- Sponsor
- IRCCS Azienda Ospedaliero-Universitaria di Bologna · Other
Who this trial is looking for
This trial is looking for patients with advanced non-small cell lung cancer (NSCLC) who need a specific type of lung cancer test called NGS analysis. Participants will provide samples to help researchers understand more about their cancer and how to treat it.
Are You a Good Fit for This Trial?
You may be able to join if
- I am 18 years or older.
- I have suspected stage IV lung cancer confirmed by CT or PET scans.
- I need bronchoscopy for further diagnosis.
- I have received NGS analysis on a previous sample in the last five years.
- I understand the information provided and give my written consent.
You may not be able to join if
- I have small cell lung cancer.
- I have any other type of lung cancer that does not need NGS testing.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Patients with advanced non-small cell lung cancer (NSCLC) usually undergo biopsies to obtain cytological material on which to perform Next Generation Sequencing (NGS) analysis, with the aim of identifying driver gene mutations that may be targeted by specific therapies. With the development of drugs with specific therapeutic targets, the clinical need for re-biopsy or even repeated biopsies is inc…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age ≥ 18 years;
* Indication for bronchoscopic cytological sampling for further diagnosis of suspected stage IV lung cancer on CT (computed tomography)/PET (positron emission tomography) scans, with consequent need for NGS analysis.
* Indication for bronchoscopy in patients wi…
Contacts